$0.00
-$0.01 (85.92%)
Overview
Overview
Financials
SEC Filings
Executives
News
Specialized Tools
Valuations
P
Insider Transactions
P
Congressional Trades
P
Scorpius Holdings, Inc.
nighthawkbio.comScorpius Holdings, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company is headquartered in San Antonio, Texas and currently employs 89 full-time employees. The company went IPO on 2013-07-24. The firm was previously a contract development and manufacturing organization.
Financial snapshot data is not available right now.
Loading...
